Resources

Dual Use Research of Concern and Pathogens With Enhanced Pandemic Potential (DURC/PEPP)

For Researchers and Administrative Staff:

Research oversight is a critical component of effective biosafety and biosecurity practices and the responsible conduct of research involving biological agents and toxins. As part of ongoing updates and assessments of existing policies, the United States Government (USG) released the May 2024 DURC/PEPP Policy and associated Implementation Guidance, which supersedes the previous Federal DURC Policies. The new DURC/PEPP Policy defines and outlines oversight requirements for two categories of research at USG-funded institutions — “Category 1 research” involving dual use research of concern (DURC), and “Category 2 research” involving pathogens with enhanced pandemic potential (PEPP).

The DURC/PEPP Policy expands oversight of DURC to a wider scope of agents including all Select Agents and Toxins, all Risk Group 4 and most Risk Group 3 agents listed in the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (NIH Guidelines), and biological agents added during future updates to the DURC/PEPP Policy Implementation Guidance. There will be new oversight roles for researchers, applicants, recipients, and granting agencies. The DURC/PEPP Policy addresses the identification and mitigation of biosafety, biosecurity, and information risks associated with manipulation of certain pathogens that could cause significant harm to society, be it accidental or intentional. Updates reflect the evolving nature of scientific and technological risks. 

General Expectations for Institutions and Researchers

Institutions, through their researchers, must assess their research at the proposal stage and continuously throughout the research life cycle for whether the research falls under the scope of Category 1 and/or Category 2 research as described in the DURC/PEPP Policy and Implementation Guidance. To assist with this, UH is providing links to general information about DURC/PEPP, as well as a PI Self-Assessment Tool, in the myGrant proposal questionnaire. Detailed training on DURC/PEPP is also available and highly recommended for researchers via the Collaborative Institutional Training Initiative (CITI Program). Those who have potential Category 1 or 2 research will be required to take this training.

For potential Category 1 or Category 2 research projects, once the applicant receives notification from the granting agency to provide supporting materials, the researcher must work with their Institutional Review Entity (IRE) to determine whether it meets the definition of Category 1 or Category 2. Researchers must also work with their IRE to develop a risk-benefit assessment and risk mitigation plan, as applicable, that must be approved by the granting agency before work can begin or continue. 

Granting agencies will require institutional assessments of awards that are active at the time the policy goes into effect. The UH IBC and IRE will review new and ongoing research at UH to fulfill this institutional requirement of identifying potential DURC/PEPP projects. Researchers may receive a notification to complete a DURC/PEPP form in addition to his/her IBC registration form if the IBC deems that further review is needed to properly asses the project.

Please contact the UH IBC via email with any questions about this notice. Addition notices and clarification may be sent as they are received from federal agencies. 

Hawai‘i DLNR Regulations & Permits Policy

The state of Hawai‘i has regulations on the Collection and Possession of certain species or artifacts, Commercial Activity, Access to certain areas, and use of particular equipment for SCIENTIFIC, EDUCATIONAL OR PROPAGATION PURPOSES – HRS 187A-6. Any person with a bona fide scientific, educational or propagation purpose must apply in writing to obtain a Special Activity Permit to legally take certain specimens, use certain gear, and gain entrance into certain areas otherwise prohibited. Please consult Guidelines for Research, Collection, Possession, Commercial Activity, and Access Permits.

Inspections Procedures

All research, teaching, and testing facilities that store or use infectious agents or toxins must be inspected at least annually.

Contact biosafe@hawaii.edu to schedule an inspection
(808) 956-2285

See “Forms and Templates” for Lab-specific Inspection Checklists.

Inventory (Laboratory) Procedures

A Laboratory Inventory Declaration (LID) of all biological agents and toxins must be completed annually and submitted to ORC.

Contact biosafe@hawaii.edu to schedule an inspection
(808) 956-2285

“Biomaterials” include but are not limited to plants, animals, arthropods, invertebrates, insects, bacteria, viruses, parasites, fungi, oomycetes, mycoplasmas, RNA, recombinant DNA, prions, proteins, GMOs, cell lines [specify if transformed, immortalized], tissues (e.g., blood, lung), human specimens (sputum, urine, feces, tissue, swabs), non-human animal specimens, fetal calf serum, algae, protoclones and nematodes, weeds, biological control agents (including those not presently discovered or known to exist in Hawai‘i) and “new” microorganisms identified as those “combining genetic material from organisms in different genera.”

See “Forms and Templates” for Lab Declaration forms.

Biosafety Program Services for Non-UH Entities

U.S. Biological Safety Campaign

To better protect public health, the White House and NIH has urged us to review biosafety and biosecurity procedures, and to continue our sustained inventory monitoring. Take time to

  • Clean out refrigerators and freezers, discard waste appropriately, and decontaminate
  • Create or update an accurate inventory of infectious agents and biotoxins
  • Update your biosafety training
  • Contact ORC for assistance with any biosafety issues of concern

For further information:

Associations

Fact Sheets

Dengue in Hawai‘i

Mold Information

Federal Agencies

Federal Regulations

International

Local Regulations

Other Resources